🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Transplantation and Cellular Therapy Journal astctjournal.org/article/S2666-…

A patient once asked me this question and I thought, surely we must have data to answer it 🙌🏽 This will be presented during the oral abstract session on June 02 at #ASCO25 #MedTwitter Hans Messner Allogeneic BMT Program

PTCy is here to stay 💪🏽 Dose optimization is the next step 🙌🏽 We initiated a pilot project exploring PTCy ⤵️ in patients receiving MUD HSCT for AML. Here is our abstract, now out in Journal of Clinical Oncology, the #ASCO25 supplement 👇🏽 ascopubs.org/doi/10.1200/JC…

So I made it to #ASCO25 and I have to say that I’ve never felt so utterly lost amidst all these awesome MedOnc folks! At some point someone’s going to catch on that I’m only a transplanter… <<Impostor Syndrome Intensifies>>

Conditioning regimens for second allogeneic hematopoietic stem cell transplantation for patients with primary graft failure Transplantation and Cellular Therapy Journal Congratulations 👏 🎊𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM astctjournal.org/article/S2666-…

Graduation season! One group of "super-seniors" currently graduating are residency and fellowship trained doctors - who have done typically at least 7 (commonly 10 or more) years after college to become experts who may now practice independently. Sharing what I said recently:

PTCy is the standard, regardless of donor or conditioning. I haven’t given MTX (outside of 1703) since 2018. 🚫 Death due to GVHD <1% with PTCy and 7-8/8 PBSC grafts. Still room for improvement, mostly thru burden/relapse reduction.

Queralt Salas Hospital Clínic to present “HCT #Frailty Scale (HCT-FS) for Assessing Frailty in Allogeneic Hematopoietic Cell Transplant Patients. Results from a Multicenter and Prospective Canadian 🇨🇦 and Spanish 🇪🇸 Initiative” at #EHA2025 #hematology #bmtsm

Today is #WorldSickleCellDay! If you will be having an allogeneic stem cell transplant for sickle cell, this eLearning will explain the process and what to expect. Hans Messner Allogeneic BMT Program pmcancerclasses.ca/course/view.ph…

📢 Now available online ! Full article : Comparable response rates of venetoclax 50 mg with posaconazole versus venetoclax 400 mg despite lower pharmacokinetic exposure in newly diagnosed acute myeloid leukemia: less is enough 👉tandfonline.com/doi/full/10.10… #asco2025 poster,